Janssen Search
Search results
Story – Going Green in Switzerland
Going Green in Switzerland One J&J Zug, a Johnson & Johnson Family of Companies regional headquarters in Zug, Switzerland, is a state-of-the-art facility designed to meet 21 st century needs. The local team focuses on how its facilities improve ...
Mental Health Partnerships in Asia Pacific
Fostering Mental Health Partnerships in Asia Pacific In Asia Pacific, as in many regions around the world, there is a stigma surrounding mental illness, resulting from a lack of awareness and education about mental health disorders. Despite their high ...
See the Change, Be the Change
See the Change; Be the Change – Global Regulatory Affairs Colleagues Are Shaping the Future As Nelson Mandela said, “Education is the most powerful weapon which you can use to change the world.” Each September, I think about the millions of eager students ...
Partnering with NYU to Evaluate CU Requests
Partnership to Help Patients Request Access to Investigational Medicines Decisions on compassionate use (CU) requests are some of the most difficult that any company can face. To enhance our long-standing commitment to ethical and patient-centered ...
Teri L. Lawver
TERI L. LAWVER WORLDWIDE VICE PRESIDENT IMMUNOLOGY Teri Lawver is Worldwide Vice President for the Immunology Therapeutic Area with Janssen Pharmaceutical Companies of Johnson & Johnson. Together with the Immunology Research & Development ...
Joseph Hedrick, Ph.D.
JOSEPH HEDRICK, PH.D. HEAD, TYPE 1 DIABETES VENTURE WORLD WITHOUT DISEASE ACCELERATOR As Head of the Type 1 Diabetes (T1D) Venture within the World Without Disease Accelerator (WWDA), Joe leads efforts utilizing the rapidly emerging science of immune ...
Jan Wehkamp, M.D.
JAN WEHKAMP, M.D. VICE PRESIDENT GASTROENTEROLOGY DISEASE AREA LEADER Jan Wehkamp, M.D. is Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, he is responsible ...
WCLC 2021
--> Welcome to the Janssen Oncology WCLC Virtual Newsroom At the Janssen Pharmaceutical Companies of Johnson & Johnson, our commitment to patients, caregivers and clinicians goes beyond medicine. Our goals are big. We aim to eliminate cancer. ...
Kevin Hamill
KEVIN HAMILL VICE PRESIDENT JANSSEN BUSINESS DEVELOPMENT IMMUNOLOGY Kevin Hamill is Vice President, Business Development for the Immunology Therapeutic Area (TA) at Johnson & Johnson Innovation, Janssen Business Development. In this role, he leads all ...
ASCO 2023
Welcome to the Janssen Oncology Virtual Newsroom Peter Lebowitz, M.D., Ph.D. Global Therapeutic Area Head Oncology Janssen Research & Development, LLC Tyrone Brewer U.S. President Oncology Janssen Biotech, Inc. Latest News Janssen Highlights ...